ABC Challenges FCC Renewal Process Files Early Station License Applications Amid Controversy Nvidia Shares Dip 13 Despite 745 Billion Profit and 102 Billion Buyback Australian Taxpayers Subsidise Big Minings Fossil Fuel Use by 4bn a Year Report Reveals Magnificent Seven Deliver Strongest Earnings in Nearly Five Years Raising Bubble Debate Indias Gold Loan Lenders Poised for Growth as Higher Import Tariffs Boost Domestic Gold Prices Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project DMRA Q1 2026 Earnings WiderThanExpected Loss Sends Shares Lower NPWR Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Company Advances Technology DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending Lear Corporation LEA Q1 2026 Earnings Solid EPS Beat Drives Modest Share Gain STZ Q1 2026 Earnings EPS Surprises to the Upside Stock Slips CNXC Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges Stock Rises Grupo Aeroportuario Del Pacifico PAC Rises 239 as Air Travel Demand Supports Rebound Precision BioSciences DTIL Faces Significant Decline Testing Key Support Levels Gentex Corporation GNTX Edges Higher Testing Key Resistance at 2524 Novo Nordisk NVO Climbs 215 as Shares Approach Key Resistance Near 48 Canadian Natural Resources CNQ Faces Selling Pressure After Steep Decline Shah Metacorp Surges 6 on 498 Crore Rights Issue for Expansion and Renewable Energy Entry AST SpaceMobile Q1 2026 Earnings Deep Loss Misses Expectations Yet Stock Soars on Strategic Progress Q32 Bio Inc QTTB Surges 81 on Heavy Volume Key Levels to Watch Virtus AI Tech Opportunities Fund AIO Holds Steady Near Support After Modest Uptick Clearfield Inc CLFD Surges Nearly 5 as Stock Breaks Above Key Support Level Progress Software PRGS Gains Momentum as Price Approaches Key Resistance Titan Acquisition Corp Units TACHU Holds Steady at 1045 as SPAC Investors Eye Potential Merger Catalyst Pilgrims Pride PPC Edges Lower as Chicken Sector Faces Headwinds Redwood Trust Senior Notes RWTP Edge Lower Amid Modest Trading 2439 Support and Resistance Levels in Focus Heron Therapeutics HRTX Slides to 086 as Selling Pressure Persists